Congenital rubella syndrome : A brief review of public health perspectives
Congenital rubella syndrome (CRS) is one of the most devastating congenital infections and yet the only one which is vaccine preventable and is a public health challenge for clinicians and policymakers across the developing world including India. The clinical manifestations of CRS include growth retardation, cardiac defects, cataracts, and hearing impairment. The World Health Organization (WHO) estimates that worldwide over 100,000 babies are born with CRS every year despite the availability of safe and inexpensive vaccines, thus highlighting the need for broader vaccination coverage programs. This article briefly reviews the importance of CRS, the proposed strategies for prevention by the WHO, and the "Rubella initiative" that Government of India is launching in view of the recognition of CRS as a significant problem in India.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:62 |
|---|---|
| Enthalten in: |
Indian journal of public health - 62(2018), 1 vom: 29. Jan., Seite 52-54 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kaushik, Ashlesha [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Congenital rubella syndrome |
|---|
| Anmerkungen: |
Date Completed 24.09.2019 Date Revised 25.09.2019 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.4103/ijph.IJPH_275_16 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM281694915 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM281694915 | ||
| 003 | DE-627 | ||
| 005 | 20231225032223.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4103/ijph.IJPH_275_16 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0938.xml |
| 035 | |a (DE-627)NLM281694915 | ||
| 035 | |a (NLM)29512566 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kaushik, Ashlesha |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Congenital rubella syndrome |b A brief review of public health perspectives |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.09.2019 | ||
| 500 | |a Date Revised 25.09.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Congenital rubella syndrome (CRS) is one of the most devastating congenital infections and yet the only one which is vaccine preventable and is a public health challenge for clinicians and policymakers across the developing world including India. The clinical manifestations of CRS include growth retardation, cardiac defects, cataracts, and hearing impairment. The World Health Organization (WHO) estimates that worldwide over 100,000 babies are born with CRS every year despite the availability of safe and inexpensive vaccines, thus highlighting the need for broader vaccination coverage programs. This article briefly reviews the importance of CRS, the proposed strategies for prevention by the WHO, and the "Rubella initiative" that Government of India is launching in view of the recognition of CRS as a significant problem in India | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Congenital rubella syndrome | |
| 650 | 4 | |a public health | |
| 650 | 4 | |a rubella initiative | |
| 650 | 7 | |a Rubella Vaccine |2 NLM | |
| 700 | 1 | |a Verma, Sanjay |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Praveen |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Indian journal of public health |d 1961 |g 62(2018), 1 vom: 29. Jan., Seite 52-54 |w (DE-627)NLM000227773 |x 0019-557X |7 nnns |
| 773 | 1 | 8 | |g volume:62 |g year:2018 |g number:1 |g day:29 |g month:01 |g pages:52-54 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4103/ijph.IJPH_275_16 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 62 |j 2018 |e 1 |b 29 |c 01 |h 52-54 | ||